IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Dasra Healthcare IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Bhilwara and caters to Healthcare sector. Mark Corporate Advisors Private is the merchant banker of Dasra Healthcare IPO. It is a SME UPCOMING IPO which filed its Draft Red Herring Prospectus (DRHP) on 24th December 2024.
Dasra Healthcare IPO posted revenues of Rs 49.48 crores and PAT of Rs 9.67 crores in FY25 on annualised basis.Financial results of Dasra Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Dasra Healthcare IPO PAT Margin is 19.56%, ROCE (Return on Capital Employed) is 21.00% as per latest financial. The below table shows Dasra Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Dasra Healthcare IPO is Rs [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Dasra Healthcare IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Dasra Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Dasra Healthcare IPO is ₹[●] Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Dasra Healthcare IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Dasra Healthcare IPO reported revenue of ₹49.48 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Dasra Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Dasra Healthcare recorded an EBITDA of ₹ 17.21 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Dasra Healthcare Profit After Tax (PAT) is ₹9.67 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 49.44 Cr.
EBITDA Margin:
34.81
%
Net Worth: ₹ 13.11 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: [●]
Dasra Healthcare operates in Healthcare and . The Issue is listed on NSE EMERGE in Apr, 2025. Dasra Healthcare IPO size was with Issue price of .
Merchant Banker(s) of Dasra Healthcare IPO: Mark Corporate Advisors Private Limited
Dasra Healthcare IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Dasra Healthcare IPO listed at a listing price of against the offer price of .
The current market price of Dasra Healthcare is .
Why Us?
